OBJECTIVE: To estimate whether prenatal exposure to acetaminophen is associated with risk of diagnosed asthma and asthma symptoms in children. METHODS: The authors prospectively followed 1,505 pregnant women and their children until 6 years (+/-3 months) of life. Acetaminophen use in the first and third trimesters of pregnancy was assessed before 24 weeks of gestation and within 1 month of delivery, and asthma in children was assessed when the child was 6 years old. Adjusted odds ratios (aORs) were derived from logistic regression models controlling for potential confounders. RESULTS: Acetaminophen was used by 69% of women during pregnancy. Use of acetaminophen did not significantly increase the risk of asthma (aOR 0.76, 95% confidence interval [CI] 0.53-1.10). Acetaminophen use during both the first and the third trimester was associated with a significantly reduced risk of asthma (aOR 0.59, 95% CI 0.36-0.98). There was no evidence of a dose response, and consumption greater than 10,400 mg (32 tablets) a month did not increase risk (aOR 0.99, 95% CI 0.19-5.30). CONCLUSION: Our results suggest that acetaminophen use during pregnancy does not increase risk of asthma in children. LEVEL OF EVIDENCE: II.
OBJECTIVE: To estimate whether prenatal exposure to acetaminophen is associated with risk of diagnosed asthma and asthma symptoms in children. METHODS: The authors prospectively followed 1,505 pregnant women and their children until 6 years (+/-3 months) of life. Acetaminophen use in the first and third trimesters of pregnancy was assessed before 24 weeks of gestation and within 1 month of delivery, and asthma in children was assessed when the child was 6 years old. Adjusted odds ratios (aORs) were derived from logistic regression models controlling for potential confounders. RESULTS:Acetaminophen was used by 69% of women during pregnancy. Use of acetaminophen did not significantly increase the risk of asthma (aOR 0.76, 95% confidence interval [CI] 0.53-1.10). Acetaminophen use during both the first and the third trimester was associated with a significantly reduced risk of asthma (aOR 0.59, 95% CI 0.36-0.98). There was no evidence of a dose response, and consumption greater than 10,400 mg (32 tablets) a month did not increase risk (aOR 0.99, 95% CI 0.19-5.30). CONCLUSION: Our results suggest that acetaminophen use during pregnancy does not increase risk of asthma in children. LEVEL OF EVIDENCE: II.
Authors: L Garcia-Marcos; M Sanchez-Solis; V Perez-Fernandez; M D Pastor-Vivero; P Mondejar-Lopez; J Valverde-Molina Journal: Int Arch Allergy Immunol Date: 2008-11-26 Impact factor: 2.749
Authors: R Graham Barr; Catherine C Wentowski; Gary C Curhan; Samuel C Somers; Meir J Stampfer; Joel Schwartz; Frank E Speizer; Carlos A Camargo Journal: Am J Respir Crit Care Med Date: 2004-01-07 Impact factor: 21.405
Authors: Elizabeth W Triche; Lisbet S Lundsberg; Paige G Wickner; Kathleen Belanger; Brian P Leaderer; Michael B Bracken Journal: Ann Allergy Asthma Immunol Date: 2011-01-08 Impact factor: 6.347
Authors: H W Chu; C M Lloyd; W Karmaus; P Maestrelli; P Mason; G Salcedo; J Thaikoottathil; A J Wardlaw Journal: Clin Exp Allergy Date: 2010-11 Impact factor: 5.018
Authors: Joanne E Sordillo; Christina V Scirica; Sheryl L Rifas-Shiman; Matthew W Gillman; Supinda Bunyavanich; Carlos A Camargo; Scott T Weiss; Diane R Gold; Augusto A Litonjua Journal: J Allergy Clin Immunol Date: 2014-10-28 Impact factor: 10.793